Max Robotics — Global Service Robot Directory + US Certification

About

Robert Wylie is a pioneering researcher at the intersection of soft robotics, mechanobiology, and drug delivery, with a core focus on overcoming the foreign body response (FBR) to extend therapeutic lifespan. His major contributions center on developing dynamic, actuation-based implantable platforms that actively combat fibrous capsule (FC) formation—a key barrier to molecular transport in long-term devices. In his most-cited work (2022, 43 citations), Wylie demonstrated that dynamic actuation enhances transport and prolongs drug release efficacy, directly addressing the FBR challenge. His 2024 study (8 citations) advances this concept by integrating a mechanoresponsive hydrogel with soft robotics, enabling precise, on-demand compression to control therapeutic protein release while maintaining stability against proteolytic degradation. Wylie’s research uniquely bridges materials science and robotics, offering a paradigm shift from passive to active implants. His work has significant implications for chronic disease management, reducing administration frequency and improving patient outcomes. With a growing citation impact and a focus on translational innovation, Wylie is shaping the future of smart, responsive drug delivery systems.